Stuttering clinical trials at UCSF

1 research study open to eligible people

Stuttering is a speech disorder that affects the fluency of talking. UCSF is testing the drug aripiprazole in adults who stutter. UCSF is recording speech and brain signals during study visits.

Showing trials for

  • Dopamine and Sensorimotor Function in Stuttering

    open to eligible people ages 18-65

    This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency. This study aims to understand sensorimotor pathways of stuttering and possible interventions.

    San Francisco, California

Our lead scientists for Stuttering research studies include .

Last updated: